Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Ocular surface reconstruction with human amniotic membrane-symblepharon ring complex.

Ghaddar H, Teja S, Conlon R, Teichman J, Yeung S, Baig K.

Can J Ophthalmol. 2016 Aug;51(4):e129-e131. doi: 10.1016/j.jcjo.2016.04.022. Epub 2016 Jun 24. No abstract available.

PMID:
27521682
2.

Results of a phase II trial of gemcitabine in patients with non-small-cell lung cancer and a performance status of 2.

Neubauer MA, Reynolds CH, Joppert MG, Whitaker T, Ghaddar H, Marsland TA, Asmar L.

Clin Lung Cancer. 2005 Jan;6(4):245-9.

PMID:
15694017
3.

Phase I trial of the angiogenesis inhibitor TNP-470 for progressive androgen-independent prostate cancer.

Logothetis CJ, Wu KK, Finn LD, Daliani D, Figg W, Ghaddar H, Gutterman JU.

Clin Cancer Res. 2001 May;7(5):1198-203.

4.

Correlation of factor VIIa values with factor VII gene polymorphism, fasting and postprandial triglyceride levels, and subclinical carotid atherosclerosis.

Ghaddar HM, Folsom AR, Aleksic N, Hearne LB, Chambless LE, Morrissey JH, Wu KK.

Circulation. 1998 Dec 22-29;98(25):2815-21.

PMID:
9860781
5.

Amsacrine and continuous-infusion high-dose cytosine arabinoside as induction therapy for patients with newly-diagnosed acute myelogenous leukemia.

Ghaddar HM, Pierce S, Kantarjian HM, Freireich EJ, Keating MJ, Estey EH.

Leuk Lymphoma. 1996 Jun;22(1-2):71-6.

PMID:
8724530
6.

Factors predicting complete remission and subsequent disease-free survival after a second course of induction therapy in patients with acute myelogenous leukemia resistant to the first.

Anderlini P, Ghaddar HM, Smith TL, Pierce S, Kantarjian HM, O'Brien S, Keating MJ, Freireich EJ, Estey EH.

Leukemia. 1996 Jun;10(6):964-9.

PMID:
8667653
7.

Treatment of newly-diagnosed acute myelogenous leukaemia in patients aged 80 years and above.

DeLima M, Ghaddar H, Pierce S, Estey E.

Br J Haematol. 1996 Apr;93(1):89-95.

PMID:
8611481
8.

A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients.

Raad II, Whimbey EE, Rolston KV, Abi-Said D, Hachem RY, Pandya RG, Ghaddar HM, Karl CL, Bodey GP.

Cancer. 1996 Apr 1;77(7):1386-94.

PMID:
8608520
9.

Correlation of specific platelet activation markers with carotid arterial wall thickness.

Ghaddar HB, Cortes J, Salomaa V, Kark JD, Davis CE, Folsom AR, Heiss G, Stinson V, Wu KK.

Thromb Haemost. 1995 Sep;74(3):943-8.

PMID:
8571326
10.

Treatment of acute myelogenous leukemia.

Ghaddar H, Anderlini P, Estey E.

N Engl J Med. 1995 Jun 22;332(25):1717-8; author reply 1718-9. No abstract available.

PMID:
7760880
11.
12.

ARIC hemostasis study--IV. Intraindividual variability and reliability of hemostatic factors. The Atherosclerosis Risk in Communities (ARIC).

Nguyen ND, Ghaddar H, Stinson V, Chambless LE, Wu KK.

Thromb Haemost. 1995 Feb;73(2):256-60.

PMID:
7792740
14.

Long-term results following treatment of newly-diagnosed acute myelogenous leukemia with continuous-infusion high-dose cytosine arabinoside.

Ghaddar HM, Plunkett W, Kantarjian HM, Pierce S, Freireich EJ, Keating MJ, Estey EH.

Leukemia. 1994 Aug;8(8):1269-74.

PMID:
8057660

Supplemental Content

Loading ...
Support Center